– VYLOY is the first and only CLDN18.2-targeted treatment approved in the India for adult patients with HER2 negative gastric and gastroesophageal junction (GEJ) adenocarcinoma whose tumors are CLDN18.2 positive – – Central Drugs Standard Control Organization approval was based on the global Phase 3 trials GLOW & SPOTLIGHT where the combination treatment extended median overall survival …
Every year, lakhs of students prepare for NEET 2027 with the dream of securing a seat in a top medical college. While Biology carries the highest weightage, Physics is often the subject that decides the final rank. The right mentor can simplify difficult concepts, improve numerical-solving skills, and build the confidence needed to score well …
New Delhi, July 30, 2026: B L Kashyap & Sons Ltd. (BSE: 532719 | NSE: BLKASHYAP), one of India’s leading Engineering, Procurement, and Construction (EPC) companies, has secured a new order valued at approximately ₹91.57 crore (excluding GST) from Embassy Development Ltd. The order involves the execution of civil and structural works for the residential …
Hyderabad / Shimla, July 30th, 2026: Olectra Greentech Limited, India’s leading electric mobility company, has become the first company in India to deploy 4,000 electric buses on Indian roads. This landmark achievement marks a defining moment in the country’s electric mobility journey and reinforces Olectra’s leadership in accelerating India’s transition towards sustainable public transportation. The …
